501029-36-3 Usage
Uses
Used in Pharmaceutical Industry:
[1,1'-Biphenyl]-4-acetic acid, a-[[4-[3-(5-methyl-2-phenyl-4-oxazolyl)-1-propynyl]phenyl]methyl]is used as a potential pharmaceutical compound for its unique structure and properties. It may be further researched and developed for specific therapeutic applications, such as targeting certain diseases or conditions.
Used in Materials Science:
In the field of materials science, [1,1'-Biphenyl]-4-acetic acid, a-[[4-[3-(5-methyl-2-phenyl-4-oxazolyl)-1-propynyl]phenyl]methyl]could be utilized in the development of new materials with specific properties, such as improved strength, flexibility, or chemical resistance.
Used in Organic Chemistry:
[1,1'-Biphenyl]-4-acetic acid, a-[[4-[3-(5-methyl-2-phenyl-4-oxazolyl)-1-propynyl]phenyl]methyl]may also be used as a starting material or intermediate in the synthesis of other complex organic compounds. Its unique structure could be exploited to create novel molecules with specific functions or properties.
Further research and analysis of [1,1'-Biphenyl]-4-acetic acid,
a-[[4-[3-(5-methyl-2-phenyl-4-oxazolyl)-1-propynyl]phenyl]methyl]- are necessary to fully understand its properties and potential applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 501029-36-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,1,0,2 and 9 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 501029-36:
(8*5)+(7*0)+(6*1)+(5*0)+(4*2)+(3*9)+(2*3)+(1*6)=93
93 % 10 = 3
So 501029-36-3 is a valid CAS Registry Number.
501029-36-3Relevant academic research and scientific papers
Effects of modifications of the linker in a series of phenylpropanoic acid derivatives: Synthesis, evaluation as PPARα/γ dual agonists, and X-ray crystallographic studies
Casimiro-Garcia, Agustin,Bigge, Christopher F.,Davis, Jo Ann,Padalino, Teresa,Pulaski, James,Ohren, Jeffrey F.,McConnell, Patrick,Kane, Christopher D.,Royer, Lori J.,Stevens, Kimberly A.,Auerbach, Bruce J.,Collard, Wendy T.,McGregor, Christine,Fakhoury, Stephen A.,Schaum, Robert P.,Zhou, Hairong
, p. 4883 - 4907 (2008/12/21)
A new series of α-aryl or α-heteroarylphenyl propanoic acid derivatives was synthesized that incorporate acetylene-, ethylene-, propyl-, or nitrogen-derived linkers as a replacement of the commonly used ether moiety that joins the central phenyl ring with
Antidiabetic agents
-
, (2008/06/13)
The present invention provides compounds of Formula (I): wherein A, X, Q, Y, B, D, Z, and E have any of the values defined in the specification, and pharmaceutically acceptable salt thereof, that are useful as antidiabetic agents. Also disclosed are pharmaceutical compositions comprising one or more compounds of Formula I, processes for preparing compounds of Formula I, and intermediates useful for preparing compounds of Formula I.
